Condition: Psoriasis (PsO) · Sponsor: Huabo Biopharm Co., Ltd.
This study is a randomized, double-blind phase 2 clinical trial aimed at exploring the efficacy, safety, and immunogenicity of HB0017 injection with different dosing regimens in the treatment of moderate to severe plaque psoriasis in subjects
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, Anhui, China | Recruiting |
| Southern Medical University Dermatology Hospital | Guangzhou, Guangdong, China | Recruiting |
| Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| Wuxi Second People's Hospital | Wuxi, Jiangsu, China | Recruiting |
| Jiangsu University Affiliated Hospital | Zhenjiang, Jiangsu, China | Recruiting |
| Jilin University Second Hospital | Changchun, Jilin, China | Recruiting |
| Shandong First Medical University Affiliated Dermatology Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Jining First People's Hospital | Jining, Shandong, China | Recruiting |
| Xingtai People's Hospital | Xingtai, Shandong, China | Recruiting |
| Shanxi Medical University Second Hospital | Taiyuan, Shanxi, China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, Sichuan, China | Recruiting |
| Chongqing Traditional Chinese Medicine Hospital | Chongqing, Sichuan, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06592274